The drug development start-up TPP Global Development has agreed its first deal, in which it will collaborate with Edinburgh University to carry out preclinical development.
This month sees the opening of the new Kosterlitz Centre for Therapeutics at Aberdeen University, which will provide specialist skills for applying and commercialising medical research.
Don’t punish companies that fail to deliver risky projects. Help them do better next time, says David Bott, Director of Innovation Programmes at the Technology Strategy Board.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.